MedTrace Logo

Evaluation of Apexogenesis With Human Treated Dentin Matrix in Young Permanent Molars

NCT05830695 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-07-30

No results posted yet for this study

Summary

Assess the clinical, radiographic, and tomographic outcomes of apexogenesis with human treated dentin matrix in young permanent molars compared to MTA.

Conditions

  • Dentin Bridge

Interventions

DRUG

human treated dentin matrix

human treated dentin matrix is compared with mineral trioxide aggregate in apexogenesis

DRUG

Mineral Trioxide Aggregate

mineral trioxide aggregate was used as control

Sponsors & Collaborators

  • nora mostafa mohammed abo shanady

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-18
Primary Completion
2022-07-18
Completion
2023-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05830695 on ClinicalTrials.gov